Neuronal plasma membrane lipid raft (MLR)

Neuronal plasma membrane lipid rafts are specialized, dynamic microdomains enriched in cholesterol, sphingolipids (such as gangliosides), and specific scaffolding proteins like flotillins and caveolins [nih.gov, mdpi.com]. They serve as essential organizing platforms for signal transduction, particularly for neurotrophic factors (e.g., BDNF/TrkB) and neurotransmitter receptors (e.g., NMDA, GABA, 5-HT3), thereby regulating synaptic plasticity, axon guidance, and neuronal survival [nih.gov, oup.com]. In neurodegenerative diseases like Alzheimer's and Parkinson's, alterations in raft composition—often linked to aging or dysregulated lipid metabolism—promote the aggregation of toxic proteins (e.g., amyloid-beta, alpha-synuclein) and aberrant signaling [nih.gov, mdpi.com]. Therapeutic strategies targeting these rafts include the use of cholesterol-modulating agents like statins or specific raft antagonists like Oxy210 to restore membrane homeostasis or disrupt pathological protein clustering [nih.gov, oup.com]. Common biomarkers used to assess raft integrity and composition include flotillins, caveolins, and ganglioside GM1 [mdpi.com, nih.gov]. However, because lipid rafts are fundamental to normal neuronal function and development, pharmacological intervention carries risks of disrupting vital signaling pathways and synaptic integrity [frontiersin.org, nih.gov].

Other names

Membrane lipid raftDetergent-resistant membrane (DRM)Lipid microdomainCholesterol-rich microdomainSphingolipid-rich microdomain

Mechanisms include the depletion of membrane cholesterol to disrupt raft assembly, the use of small-molecule antagonists to reverse pathological raft expansion, and the modulation of membrane fluidity to alter the clustering and signaling of raft-resident receptors [nih.gov, frontiersin.org].